DrugsControl Media Services

News Detail

Delhi HC refuses interim relief to AstraZeneca on alleged patent infringement of diabetes drug (22-07-2021)

New Delhi, 22 July 2021: A division bench of Delhi High Court has ordered that multinational pharmaceutical firm AstraZeneca and its Indian firm are not entitled for an interim relief in the form of an interim injunction against nine Indian pharmaceutical firms on alleged infring......
View Details

Source : Pharmabiz

Related News